Vertex Pharmaceuticals Incorporated (VRTX) Turns Up the Heat on Bears

Vertex Pharmaceuticals Incorporated's (VRTX) cystic fibrosis drug got the green light from the FDA

Jul 2, 2015 at 1:40 PM
facebook X logo linkedin


Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares shot higher today -- but are currently halted at $130.90 -- on news that the company's cystic fibrosis therapy, Orkambi, received Food and Drug Administration (FDA) approval. With its intraday lead approaching 4%, the stock has advanced 32.5% year-over-year -- though it's struggled in recent months in the $130-$133 neighborhood. Amid this recent churn, option traders have gravitated toward long puts.

Diving right in, during the last 10 days at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), speculators have bought to open 1.36 puts for every call. This ratio ranks in the 82nd percentile of its annual range, suggesting traders have bought to open puts over calls at a faster-than-usual pace lately.

Further reflecting this bias toward puts is VRTX's Schaeffer's put/call open interest ratio (SOIR) of 1.31. Not only does this SOIR indicate short-term put open interest outweighs call open interest, but it also rests above 79% of comparable readings from the previous 12 months.

Analysts are tilted in a skeptical direction, as well. Over half of the brokerages covering Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) have doled out tepid "hold" ratings. What's more, the stock's average 12-month price target of $140.10 is just 7% above the current perch -- though it does represent uncharted territory for VRTX.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI